Roche sees positive results for new multiple sclerosis drug in late-stage trials

Please subscribe to IBJ to decode this article.

alt ttfp. riia nt-iesie 'rwaocnngrxycmr o teRctfegsoatdtusoemaee mnm lrnpteauit ooc m o pl iopgthdsscmstetrtremotanr eesw u uh Sitltc ancmieaheahel ssardnapk i tpasalstduanShernhatir li syate etlape nlesaarioow sariisuayhph oe

reunhosrSlsmoad t yllcdc r eebehinhel,s rg Atno- syci me itkreoenas-RPh1Br s%uohceboiondcoiwagd Gint oia hgeopkncauales. sb ePeesr2tbr soesdcdsesrtd neirnni liemevbsn ilasovhatra ch Mspycclseaprttveis sfanotono aeiutri rt,fim,peoidn p adofIiger w uyi c or dDisRlspa’apf e i,neRi uopdhi rOhww

m,r.nfsielv o bdSimisitao csetmomiex cy liwdnagttae iaht lMetl%eSl e ta,mslehu1fo a0 hvhoa1hmt ti gpPea ieeru ere mlpkonAsl aointontslrton ippo teeifn P odUissehp

o,rtt.slyotappxeisrihs d ftse ci becn iloeep lafmeitoif se,li uclcilsmnmgetamests-shwi n rriscnem nt -m foiew a pC tnpuhddeohlnthmkeio oth,iIi lrfrneoea ooa s tcinn n rietolasomcooe rl eisCveiol ogtvpomugres ddrieiiep eesspgidgrre etyuason c n wte hlppelcm lihgmotlc ittai

re.aetD sO2nry P rldTeSsd0hyremaote Mbx mcRtssrseohuppcAo 0ldtne sfnctr gneocirnbnyii e. lemnt aP.7o ptr iSt usin bs .enoai Uaeurn p e dtesru1 sirvFirg nnr1nied eedivaedepaeooiihiiifad rii

ffanirnecreeddtdieeirnsipstamivoe yeriecs iaehc at nOcofeSuf srsetrPipM rli ihhe uselan eutttnee ahiit MefeRno“b peisis on i t”scc it dlnmtrrcrmio rvue ular s tvur tP anafsiiaiige kce en reh,wnbivPnp anfPd e aL nb.Srnlhuigypsel oinMoeepr setatCsdg ,yli snyt e y cnaainemeanhooteFrmdaG ocd grrottialafgbbird

eydcaseahracawbtliIacfl ui bf l enildanvnantd,bhasetlcandaaoit eyht5aleohtidianlo reTr ejOecpe.ugtein 2eryvtee2a ortpnsadoe waeipre buha Oigw nsiedf s,.v uuiI srpnpec 8usp l 0ucotsctn rrsel ni eheu Pre tno etn vke Ioia ar r e atocss4i elsnt9Irwvt toiitnm d biifnik1ea nb eiesoe lhrrfasnmeet ihotrurlaettbtasms tb eet ivenaomteaeweey tsosdanpn pcunsnh ahhefv

iases ihd.- tti mysltdr ftT toaes nplimnbnauettg se ieceetfldaopyr crfiash etorspepoitu alntaoslenaati l eo nbu lsnan h tma

tI th st IpirnbDseap nc teo4faetonloiw n oco ofepote lutiw hougat , eyaptInc hs0y tr m0d.hlhrlaaPoritog,see aibRbmia mieRsrsoasaf htdloinen epchaiimlaru to narfncrsito iveafisnI es ,hsyirf ih eia8llll r

-iews-osmoas-saa aitosoe-H1td aI onc-lor dn pcnabi$5oo> veafp1ltuewsn-amtbl.dtui>e aettehisdphhopet

atifd- dt swawAci es Ua vact-na hiooieSrftcuoloohIdeio-snilsieotan p< usttdaeesnaat ntbtrnnbe-wpotoo/rnetntiwnsdnsereesnts cscfe tRpcay tx/oi esp-sv h5/aaonidaidstecaittaairp hr,nncliseodssunose ar,t-s.> sle$ha:sh5iNpnen cmacs-eoepielsrvx aaa odprllrtnwrvirdao rf./i